Ura Sawako, Miyata Manabu, Ooto Sotaro, Yasuhara Satoshi, Tamura Hiroshi, Ueda-Arakawa Naoko, Muraoka Yuki, Miyake Masahiro, Takahashi Ayako, Wakazono Tomotaka, Uji Akihito, Yamashiro Kenji, Tsujikawa Akitaka
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo Ku, Kyoto City, Kyoto Prefecture, Japan ; and.
Department of Ophthalmology, Red Cross Otsu Hospital, Otsu City, Japan .
Retina. 2022 Apr 1;42(4):661-668. doi: 10.1097/IAE.0000000000003360.
To investigate predictors of early displacement of submacular hemorrhage (SMH) by simple intravitreal SF6 gas injection.
This retrospective study included 16 eyes of 16 consecutive patients (age: 74.5 ± 7.7 years; 15 men) with large SMH treated with simple intravitreal SF6 gas before inception of subretinal tissue plasminogen activator injection at our institution. The SMH displacement was graded at 1-week posttreatment as 0, 1, or 2. Central retinal thickness, central choroidal thickness, SMH height, SMH area, disease duration, use of anticoagulant or antiplatelet drugs, and contrast-to-noise ratio (CNR) of SMH on optical coherence tomography images were recorded. Correlations between displacement grading and baseline parameter were analyzed.
Univariable correlation analysis revealed association of the 1-week displacement grading with the CNR (P = 0.004; r = -0.68) and SMH height (P = 0.03; r = -0.55). The CNR was most strongly associated with 1-week displacement on multivariable correlation analysis (P = 0.01; β = -0.60).
Findings of the present study showed that the CNR of SMH was a useful predictor of early displacement of large SMH after simple intravitreal SF6 gas injection. When vitrectomy with subretinal injection of tissue plasminogen activator is difficult in patients with large SMH, with low CNR on optical coherence tomography, simple intravitreal SF6 gas injection may be a treatment option.
研究单纯玻璃体腔 SF6 气体注射治疗早期黄斑下出血(SMH)移位的预测因素。
本回顾性研究纳入了 16 例(16 只眼)患者,这些患者均患有大 SMH,在本机构开始应用视网膜下组织纤溶酶原激活剂注射之前,接受了单纯玻璃体腔 SF6 气体注射治疗。治疗后 1 周,根据 SMH 移位程度将其分为 0 级、1 级或 2 级。记录中央视网膜厚度、中央脉络膜厚度、SMH 高度、SMH 面积、疾病持续时间、是否使用抗凝或抗血小板药物,以及光学相干断层扫描图像上 SMH 的对比噪声比(CNR)。分析移位分级与基线参数之间的相关性。
单变量相关分析显示,1 周移位分级与 CNR(P = 0.004;r = -0.68)和 SMH 高度(P = 0.03;r = -0.55)有关。多变量相关分析显示,CNR 与 1 周移位关系最密切(P = 0.01;β = -0.60)。
本研究结果表明,SMH 的 CNR 是单纯玻璃体腔 SF6 气体注射治疗后大 SMH 早期移位的一个有用预测因素。对于 CNR 较低的大 SMH 患者,当玻璃体切除术联合视网膜下组织纤溶酶原激活剂注射治疗困难时,单纯玻璃体腔 SF6 气体注射可能是一种治疗选择。